Development of a High-Content Stem Cell Focused Drug Screening Platform for Schistosoma mansoni Using Developmentally Advanced Liver Schistosomula - Functional Insights and New Protein Target Leads

Journal of Infectious Diseases · Published 2026-07-28 · DOI 10.1093/infdis/jiag392

Free full text

Authors (3)

Sewwandi Perera, Athina Myrto Chioni, Anthony J Walker

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Perera, S., Chioni, A., Walker, A. (2026). Development of a High-Content Stem Cell Focused Drug Screening Platform for Schistosoma mansoni Using Developmentally Advanced Liver Schistosomula - Functional Insights and New Protein Target Leads. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag392

Related articles

• Viable Schistosoma mansoni infection 41 years after last exposure—a case report of a loyal parasite · Journal of Travel Medicine · 2025 · Cites or is cited by this article
• Insights into the functional biology of schistosomes · Parasites & Vectors · 2011 · Cites or is cited by this article
• Comparative Evaluation of E6/E7 mRNA Expression and Viral DNA Load in Cervical Lesions With Multiple High-Risk Human Papillomavirus Infection · Journal of Infectious Diseases · 2026 · Same journal
• Diverse Genetic Lineages Spreading Across Healthcare and Community Boundaries Underlie Extended-Spectrum Cephalosporin-Resistant Enterobacterales Colonization Burden in Botswana · Journal of Infectious Diseases · 2026 · Same journal
• Repeated Influenza Vaccination in Children: Effect Scale, Timing, and Causal Interpretation · Journal of Infectious Diseases · 2026 · Same journal
• Influenza Attack Rates and Vaccine Effectiveness by Prior-Season Infection and Vaccination: A 17-Season Analysis · Journal of Infectious Diseases · 2026 · Same journal
• Characterization of hepatitis B virus in blood donors who were disqualified based on testing: genotype distribution, infectivity, and replicative fitness in human hepatocytes · Journal of Infectious Diseases · 2026 · Same journal
• Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 RSV Vaccine Administered 24 Months Following a Primary Dose in Adults ≥60 Years of Age · Journal of Infectious Diseases · 2026 · Same journal
• Shortening HCV Treatment in US Jails: Opportunities and Implementation Considerations · Journal of Infectious Diseases · 2026 · Same journal
• Neutralization Capacity Against SARS-CoV-2 Ancestral, Delta, and Omicron Variants Before and After Heterologous Booster Vaccination in Fijian Healthcare Workers · Journal of Infectious Diseases · 2026 · Same journal